Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Vectalys and FlashCell have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.
read more
Tuesday, January 06, 2026
Analytical Biological Services, a provider of biospecimen sourcing, cell culture services, and biorepository solutions for the global pharmaceutical and biotechnology industry, has acquired Cureline, a provider of specimen procurement and histology ...
read more
Catalent announced the expansion of its UpTempo
SM platform process for the development and CGMP manufacturing of adeno-associated viral (AAV) vectors.
read more
INC Research Holdings, a global Phase I to IV contract research organization, has announced the appointment of William E. Klitgaard and Linda S. Harty to the Company’s Board of Directors effective immediately.
read more
Monday, February 12, 2018
Daniel Dixon has been appointed vice president of Quality Control, UPM Pharmaceuticals.
read more
MedAvante a provider of technology-based clinical trial services for central nervous system (CNS) diseases, announced two new members of its Board of Directors: Richard F. Cimino, former Covance, Inc. EVP and Group President of Clinical Development ...
read more
Wednesday, February 21, 2018
Cobra Biologics and Symbiosis Pharmaceutical Services announced that they have been awarded a 16-month collaborative grant of £1.9m ($2.5m) from Innovate UK.
read more
Tuesday, November 16, 2021
Labcorp opened a new, integrated bioanalytical laboratory in Singapore. The laboratory features new capabilities that enhance the substantial array of bioanalytical services currently offered through Labcorp Drug Development, allowing the company to ...
read more
SCYNEXIS, Inc. announced today that Merck, known as MSD outside the United States and Canada, has decided to return to SCYNEXIS all development and commercialization rights for the novel antifungal compound, MK-3118, an oral glucan synthase inhibitor...
read more
Crown Bioscience announces its results for the second quarter ending June 30, 2017.
read more
Monday, February 05, 2018
SCIEX announced a co-marketing agreement with IROA Technologies.
read more
Codexis has announced the signing of a collaboration and license agreement with Takeda for the research and development of novel gene therapies for certain disease indications.
read more
Integrated drug discovery and pre-clinical solutions provider, Sygnature Discovery, has appointed Dr. David Lustig to the role of Vice President Business Development - United States.
read more
PCI announced the installation and validation of its latest comprehensive Serialization system, located at its manufacturing Center of Excellence in Tredegar, UK.
read more
Wednesday, August 08, 2018
Almac Group announced the successful MHRA registration of its High Throughput GMP Peptide manufacturing facility.
read more